Each year, 500,000 Americans suffer a
first stroke, which of course can end in death or debilitating
brain damage. The good news is that with early treatment of
ischemic stroke -- the most common type -- much of the ill
effects of stroke can be prevented or reversed. In American
hospitals, the gold standard for ischemic stroke treatment is
the clot-dissolving drug alteplase (Activase), while
the antioxidant supplement acetyl-L-carnitine (also known as
ACL or simply L-carnitine) is the first-choice European
intervention. To compare and contrast these different
approaches, I consulted Daily Health News
contributing editor Andrew L. Rubman, ND.
Dr. Rubman told me that
side-effect-prone Activase is a riskier choice than L-carnitine,
and we would be better off following the European model in
this case. Unfortunately, medicine is big business, which
means L-carnitine doesn't enter into the profit scheme of
American hospitals, and doctors only know about the
pharmaceutical options, observes Dr. Rubman. This situation
reminds me of the tale my husband sometimes tells me about how
people would be very happy solving all problems with a hammer
if they didn't know that screwdrivers also existed.
Consequently, once again we have an example of an expensive
drug trumping a safer, less expensive and potentially more
effective alternative.
A HEAD-TO-HEAD
COMPARISON
Most ischemic strokes occur when a clot
blocks an artery, cutting off blood supply to the brain.
Activase works by dissolving clots in blocked arteries, thus
restoring blood flow to the brain. However, this drug must be
given within three hours of a stroke, so few stroke victims
(about 3% to 4%) have the opportunity to take advantage of it.
After three hours, the ability of the drug to affect the clot
diminishes rapidly. Moreover, while the benefits outweigh the
risks overall, serious side effects can result. Activase
increases the risk of bleeding, including intracranial
bleeding, and hemorrhages occur in approximately 4% to 6% of
people who are given it.
In contrast, L-carnitine, a powerful
antioxidant, taken immediately and repeated every two or three
hours following an ischemic stroke, is involved in the
transport of fatty acid across cell membranes, where it is
used as energy by mitochondria (the "power plant" of
the cells). In ischemic stroke patients, L-carnitine has
improved cerebral blood flow, and had a positive impact on
abstract thinking, memory, cognition and task performance.
Additionally, although it's best to start treatment as early
as possible, even later administration of L-carnitine is
beneficial. And, there are no significant side effects at the
maximum therapeutic dosage level of 1,500 mg per day. Note:
Hemorrhagic strokes can worsen with this type of therapy, so a
doctor must decipher the type of stroke before treatment.
MARKETING TRUMPS
SCIENCE
Unfortunately, there is little awareness
of L-carnitine in the US, at least among conventional doctors,
and little economic motivation to boost its use. The
dilemma: Inexpensive L-carnitine supplements are already
available over-the-counter at your local health food store or
pharmacy, so there's little profit for pharmaceutical
companies.
To tap into valuable healing natural
resources like L-carnitine, Dr. Rubman advises that you think
outside the box and add a naturopathic physician to your
health-care team. The conventional remedy is not always the
best remedy, and an ND can help you discover a wide range of
safe and natural treatments. Modalities from botanical
medicine to homeopathy to acupuncture can go a long way toward
securing your optimal health.
Be well,
Carole Jackson
Bottom Line's Daily Health News
Best Bites & Buys
publishes the opinions/ points of view of leading authorities in
multiple fields. The use of these opinions/points of view is
in no way a substitute for legal,
accounting, investment, medical or any professional
services to suit your specific personal needs. Please,
always consult
a competent/qualified professional for answers to your specific
needs/questions.
|